Olivier Meilhac

Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study

Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis

First Recombinant High-Density Lipoprotein Particles Administration in a Severe ICU COVID-19 Patient, a Multi-Omics Exploratory Investigation

Altered high-density lipoprotein composition and functions during severe COVID-19

Relationship between lipoprotein concentrations and short-term and 1-year mortality in intensive care unit septic patients: results from the HIGHSEPS study

Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d’Athérosclérose (NSFA)

High-density lipoproteins during sepsis: from bench to bedside

Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study

High-Density Lipoproteins Are Bug Scavengers

Reconstituted High-density Lipoprotein Therapy Improves Survival in Mouse Models of Sepsis

High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects

Changes in High-Density Lipoproteins Related to Outcomes in Patients with Acute Stroke

High-density lipoprotein (HDL) particle size and concentration changes in septic shock patients

Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk

Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm

Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia